The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
Scientists are testing the ancient herb borage to see which healing claims hold up and where modern evidence still falls ...
Morning Overview on MSN
Brazilian arthritis folk cure tested, and the data looks promising
For generations, Brazilians have turned to a colorful garden plant to soothe aching joints, trusting experience long before ...
The Daily Overview on MSN
Eli Lilly closes in on a deal to buy biotech Ventyx
Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
Scientists have uncovered how a vitamin A metabolite can suppress anti-cancer immunity. Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have uncovered new ...
Sepsis, a complex syndrome driven by a dysregulated host response to infection, is closely linked to both metabolic and ...
Scientists have made a discovery that helps explain why humans and animals are so susceptible to contracting tuberculosis (TB ...
Verywell Health on MSN
Proteinuria in Complement 3 Glomerulopathy: Why It Matters and What to Do
Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
Detox diets are a trending thing on social media but do these diet plans actually work A dietician explains why real ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results